Treatment of Hypertension with ‘Miopressin’

Bakke J. L. Williams R. H. (1953. Treatment of essential hypertension with beta-alkylamines, especially dibenzyline. Amer J. Med., 14, 141

Bein H. J. (1953). Zur pharmakologie des Reserpin, eines neuen Alkaloids aus Rauwolfia serpentina Benth. Experientia (Basel), 9, 107

Corcoran A. C. Talor R. D. Harrison M. (1952). Ineffectiveness of 688A (N-phenoxyisopropyl — N — benzyl — beta — chloroethylamine hydrochloride) in treatment of essential hypertension. Proc. Soc. exp. Biol. (N. Y.), 80, 265

Duff R. S. (1956). Action of dibenzyline on the peripheral circulation. Brit. med. J. 2, 857

Gillhesby R. O. (1959). Treatment of hypertension with ‘Miopressin’. Brit. med. J., 556

Gray I. R. Hamer N. A. J. (1957). Protoveratrine A in treatment of hypertension. Brit. med. J., 2, 609

Grenfell R. F. Hilton J. G. (1960). A double-blind study of essential hypertension. J. Miss. med. Ass., 1, 235

Haimovici H. Moser M. Krakauer H. (1951). Effect of oral 688A (N-phenoxyisopropyl-N-benzyl-betachloroethylamine hydrochloride) on blood pressure in normotensives and hypertensive subjects. Proc. Soc. exp. Biol. (N.Y.), 77, 477

Hoobler S. W. Corley R. W. Kabza T. G. Loyke H. F. (1952). Treatment of hypertension with oral protoveratrine. Ann. intern. Med., 37, 465

Horwitz B. S. Wang S. C. (1956). Reserpine effect in medullary vasomotor mechanism of the cat. Fed. Proc., 15, 439

Keith N. M. Wagener H. P. Barker N. W. (1939). Some different types of essential hypertension; their course and prognosis. Amer. J. med. Set, 197, 332

Kitchin A. Lowther C. P. Turner R. W. D. (1961). Pempidine. Lancet, 1, 143

Krogsgaard A. R. (1961). On Reserpine with particular reference to its use in hypertension. Copenhagen, Munksgaard

McQueen E. G. Doyle A. E. Smirk F. H. (1954). Mechanism of hypotensive action of reserpine, an alkaloid of Rauwolfia serpentina . Nature (Lond.), 174, 1015

Moser M. Walters M. Master A. M. Taymor R. C. Metraux J. (1952). Chemical blockade of the sympathetic nervous system in essential hypertension. Arch. intern. Med., 89, 708

Moyer J. H. Handley C. A. (1952). Renal hemodynamic and blood pressure response to N-phenoxyisopropyl — N-benzyl — betachloroethylamine (SKF 688A). J. Pharmacol, exp. Ther. 104, 329

Moyer J. H. Hughes W. Dennis E. Beazley H. L. McConn R. (1955). Results with a combination of Rauwolfia and adrenergic blockade in the treatment of hypertension. Amer. J. med. Sci., 230, 33

Smith C. W. Thomas C. G. (1957). The use of a combination of hypotensive agents in mild and, moderately severe hypertension. Amer. Practit. 8, 920

Stutzman J. W. Simon H. Maison G. L. (1951). Role of vagus nerves in depressor action of veratrum derivatives. J. Pharmacol, exp. Ther. 101, 310

Taylor R. D. Page I. H. (1951). Further studies of the cerebral chemoreceptor buffers as influenced by vasoconstrictor and vasodilator drugs and veratrum viride . Circulation 4, 184

Turner R. W. D. (1959). Diagnosis and treatment of essential hypertension. Lancet, 1, 897–902; 953–58

Waldron J. M. Reinhardt D. J. Jenson W. K. Goldstein F. (1955). The treatment of diastolic hypertension with a fixed combination of hypotensive drugs. Amer. J. med. Sci., 230, 551

Woodward D. J. Hoobler S. W. Nickersonm . (1952). Effect of dibenzyline (SKF 688A) on peripheral blood flow in man Fed. Proc., 11, 404